Reduce complications through staff training

Trial ID
NCT06908460
Official Title
The Link Between the Training of Nursing Home Professionals and the Quality of Life of Residents With Parkinson's Disease
Goal
Reduce complications through staff training
Status
RECRUITING
Sponsor
University Hospital, Grenoble
Study Type
OBSERVATIONAL
Enrollment
90 participants
Conditions
Parkinson Disease

Plain-Language Summary

Researchers want to know whether training nursing home professionals can improve the daily quality of life for people living with Parkinson's disease. They will compare staff training levels and content with residents' outcomes by using questionnaires and interviews that track symptoms, daily functioning, mood, and medication management. The training is meant to help staff better recognize motor and nonmotor symptoms, time and manage levodopa and other medications safely, support mobility and daily tasks, and communicate care needs to families, which could reduce complications and boost comfort. The study plans to enroll about 90 adults aged 18 and up with a confirmed Parkinson's diagnosis who live in EHPADs in departments 38, 73, 74, 26, or 07 in the AURA region and who can cooperate with the questionnaires; residents who object or who are under certain legal protections are excluded.

Locations

  • CHU Grenoble Alpes, Grenoble, France

Frequently Asked Questions

What is this trial testing?
This trial is studying an experimental treatment. Researchers want to know whether training nursing home professionals can improve the daily quality of life for people living with Parkinson's disease. They will compare staff training levels and content with residents' outcomes by using questionnaires and interviews that track symptoms, daily functioning, mood, and medication management. The training is meant to help staff better recognize motor and nonmotor symptoms, time and manage levodopa and other medications safely, support mobility and daily tasks, and communicate care needs to families, which could reduce complications and boost comfort. The study plans to enroll about 90 adults aged 18 and up with a confirmed Parkinson's diagnosis who live in EHPADs in departments 38, 73, 74, 26, or 07 in the AURA region and who can cooperate with the questionnaires; residents who object or who are under certain legal protections are excluded.
Who can participate?
Participants must be at least 18 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 2 years and 3 months.

View on ClinicalTrials.gov